Nelson Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $274K | Sell |
2,171
-760
| -26% | -$100K | 0.03% | 105 |
|
|
2026
Q1 | $408K | Buy |
+2,931
| New | +$410K | 0.05% | 90 |
|
|
2020
Q3 | – | Sell |
-73,930
| Closed | -$5.69M | – | 98 |
|
|
2020
Q2 | $5.69M | Buy |
73,930
+3,118
| +4% | +$239K | 1.24% | 35 |
|
|
2020
Q1 | $5.29M | Buy |
70,812
+1,325
| +2% | +$91.6K | 1.42% | 31 |
|
|
2019
Q4 | $4.51M | Sell |
69,487
-1,055
| -1% | -$68.7K | 0.95% | 43 |
|
|
2019
Q3 | $4.47M | Buy |
70,542
+75
| +0.1% | +$4.9K | 1.06% | 39 |
|
|
2019
Q2 | $4.76M | Buy |
70,467
+785
| +1% | +$51.6K | 1.13% | 39 |
|
|
2019
Q1 | $4.53M | Buy |
69,682
+3,662
| +6% | +$243K | 1.13% | 39 |
|
|
2018
Q4 | $4.13M | Sell |
66,020
-13,839
| -17% | -$967K | 1.15% | 36 |
|
|
2018
Q3 | $6.17M | Buy |
79,859
+2,859
| +4% | +$216K | 1.42% | 28 |
|
|
2018
Q2 | $5.46M | Buy |
77,000
+570
| +0.7% | +$40.3K | 1.4% | 31 |
|
|
2018
Q1 | $5.76M | Buy |
76,430
+265
| +0.3% | +$21.1K | 1.49% | 27 |
|
|
2017
Q4 | $5.46M | Sell |
76,165
-392
| -0.5% | -$29.8K | 1.7% | 28 |
|
|
2017
Q3 | $6.2M | Buy |
76,557
+120
| +0.2% | +$9.18K | 2.04% | 17 |
|
|
2017
Q2 | $5.41M | Sell |
76,437
-300
| -0.4% | -$20K | 1.83% | 23 |
|
|
2017
Q1 | $5.21M | Buy |
76,737
+3,618
| +5% | +$254K | 1.75% | 25 |
|
|
2016
Q4 | $5.24M | Sell |
73,119
-10,265
| -12% | -$763K | 1.83% | 26 |
|
|
2016
Q3 | $6.6M | Buy |
83,384
+1,385
| +2% | +$113K | 2.34% | 11 |
|
|
2016
Q2 | $6.84M | Sell |
81,999
-218
| -0.3% | -$19.3K | 2.57% | 10 |
|
|
2016
Q1 | $7.55M | Buy |
82,217
+30,220
| +58% | +$2.73M | 2.85% | 6 |
|
|
2015
Q4 | $5.26M | Buy |
51,997
+200
| +0.4% | +$20.8K | 2.02% | 24 |
|
|
2015
Q3 | $5.09M | Buy |
51,797
+1,727
| +3% | +$192K | 1.95% | 24 |
|
|
2015
Q2 | $5.86M | Buy |
50,070
+1,119
| +2% | +$122K | 2.12% | 17 |
|
|
2015
Q1 | $4.8M | Sell |
48,951
-640
| -1% | -$65K | 1.73% | 29 |
|
|
2014
Q4 | $4.67M | Buy |
49,591
+65
| +0.1% | +$6.72K | 1.73% | 29 |
|
|
2014
Q3 | $5.27M | Buy |
49,526
+1,496
| +3% | +$146K | 1.99% | 21 |
|
|
2014
Q2 | $3.98M | Buy |
48,030
+1,690
| +4% | +$132K | 1.59% | 30 |
|
|
2014
Q1 | $3.28M | Buy |
46,340
+1,790
| +4% | +$140K | 1.44% | 34 |
|
|
2013
Q4 | $3.35M | Sell |
44,550
-450
| -1% | -$31.3K | 1.49% | 32 |
|
|
2013
Q3 | $2.83M | Buy |
45,000
+1,200
| +3% | +$71.7K | 1.35% | 35 |
|
|
2013
Q2 | $2.25M | Buy |
+43,800
| New | +$2.28M | 1.15% | 37 |
|
Other funds holding GILD
Nelson Capital Management's GILD Position: Q2 2026 in Review
Nelson Capital Management reduced its Gilead Sciences (GILD) stake by 26% in Q2 2026, selling an estimated $100K and leaving 2,171 shares worth $274K. The position accounts for 0.03% of the portfolio, ranked #105.
Nelson Capital Management first reported a position in GILD in Q2 2013 and has held it in 31 quarters since. The position peaked at $7.55M in Q1 2016. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Nelson Capital Management held 2,171 shares of Gilead Sciences worth $274K as of Q2 2026.
- Nelson Capital Management sold 760 Gilead Sciences shares in Q2 2026, an estimated $100K.
- Gilead Sciences made up 0.03% of Nelson Capital Management's portfolio in Q2 2026, its #105 holding.
- Nelson Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 31 quarters since.
- Nelson Capital Management's Gilead Sciences position peaked at $7.55M in Q1 2016.
- 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Nelson Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.